InvestorsHub Logo
Followers 16
Posts 4022
Boards Moderated 0
Alias Born 03/11/2003

Re: None

Thursday, 03/27/2014 11:40:37 AM

Thursday, March 27, 2014 11:40:37 AM

Post# of 34981
For those who like thrills :

"Tobin Smith Claims About PLPL:

"We initiated coverage on Plandai Biotechnology (PLPL) with a Strong Buy and $22.50 Long Term Target implying 2300%+ UPSIDE from its current market price."
"PLPL trades today around .30. My projected growth for PLPL shareholders is around $3 over next 12 monthsfollowed [sic] by stunning capital gains potential for long term buy-and-hold investors."
"In a nutshell, here is why we so STRONGLY suggest the ground floor opportunity of buying and HOLDING Plandai (PLPL) shares below 50 cents. If you know me from my decades on cable news, you know ONE thing about me--I am a STRAIGHT shooter who calls 'em like I see 'em and NOT afraid to take a strong position when I KNOW Im right."
"My equity research firm NBT Equities Research LLC STRONGLY believes Plandai Biotechnology will become the $Billion Next Big Thing in the nutritional foods industry."
"Its our strongest Strong Buy recommendationwith a short term $2.50 targetand long term $22.50 target or 23X UPSIDE from under .50 price. 2300% UPSIDE from the next $billion nutritional food company."
"Final question: What are you waiting for? BUY some shares NOW at the ground floor and DO NOT MISS this monster life changing investment opportunity." [emphasis in original]
"P.S. Im forecasting a potential 10-bagger in PLPL shares over the next 12 months, but the longer term performance looks more like a 2300% move or better."

June 2013

SOURCE:
http://mediamatters.org/print/blog/2013/06/19/meet-tobin-smith-the-dubious-stock-pitchman-fir/194529